174 related articles for article (PubMed ID: 29927606)
1. Comparative Oral Drug Classification Systems: Acetazolamide, Azithromycin, Clopidogrel, and Efavirenz Case Studies.
Mora MJ; Onnainty R; Granero GE
Mol Pharm; 2018 Aug; 15(8):3187-3196. PubMed ID: 29927606
[TBL] [Abstract][Full Text] [Related]
2. pH-Dependent solubility and permeability criteria for provisional biopharmaceutics classification (BCS and BDDCS) in early drug discovery.
Varma MV; Gardner I; Steyn SJ; Nkansah P; Rotter CJ; Whitney-Pickett C; Zhang H; Di L; Cram M; Fenner KS; El-Kattan AF
Mol Pharm; 2012 May; 9(5):1199-212. PubMed ID: 22489626
[TBL] [Abstract][Full Text] [Related]
3. The Biopharmaceutics Classification System (BCS) and the Biopharmaceutics Drug Disposition Classification System (BDDCS): Beyond guidelines.
Charalabidis A; Sfouni M; Bergström C; Macheras P
Int J Pharm; 2019 Jul; 566():264-281. PubMed ID: 31108154
[TBL] [Abstract][Full Text] [Related]
4. Biopharmaceutics classification and intestinal absorption of chikusetsusaponin IVa.
Zhang W; Liu H; Liu C
Biopharm Drug Dispos; 2019 Sep; 40(8):276-281. PubMed ID: 31294470
[TBL] [Abstract][Full Text] [Related]
5. A comparative analysis of biopharmaceutics classification system and biopharmaceutics drug disposition classification system: a cross-sectional survey with 500 bioequivalence studies.
Cristofoletti R; Chiann C; Dressman JB; Storpirtis S
J Pharm Sci; 2013 Sep; 102(9):3136-44. PubMed ID: 23580377
[TBL] [Abstract][Full Text] [Related]
6. Considerations for a Pediatric Biopharmaceutics Classification System (BCS): application to five drugs.
Gandhi SV; Rodriguez W; Khan M; Polli JE
AAPS PharmSciTech; 2014 Jun; 15(3):601-11. PubMed ID: 24557773
[TBL] [Abstract][Full Text] [Related]
7. Biopharmaceutics classification of puerarin and comparison of perfusion approaches in rats.
Li H; Dong L; Liu Y; Wang G; Wang G; Qiao Y
Int J Pharm; 2014 May; 466(1-2):133-8. PubMed ID: 24607203
[TBL] [Abstract][Full Text] [Related]
8. Application of a Refined Developability Classification System.
Rosenberger J; Butler J; Muenster U; Dressman J
J Pharm Sci; 2019 Mar; 108(3):1090-1100. PubMed ID: 30389565
[TBL] [Abstract][Full Text] [Related]
9. [Applicability analysis and evaluation of aglycones in single-pass intestinal perfusion technique based on PBPK model].
Liu Y; Zhang X; Shi XJ; Wen YX; Yang L; Dong L
Zhongguo Zhong Yao Za Zhi; 2019 Sep; 44(17):3645-3652. PubMed ID: 31602936
[TBL] [Abstract][Full Text] [Related]
10. Regional Intestinal Permeability in Rats: A Comparison of Methods.
Roos C; Dahlgren D; Sjögren E; Tannergren C; Abrahamsson B; Lennernäs H
Mol Pharm; 2017 Dec; 14(12):4252-4261. PubMed ID: 28920690
[TBL] [Abstract][Full Text] [Related]
11. The use of biopharmaceutic classification of drugs in drug discovery and development: current status and future extension.
Lennernäs H; Abrahamsson B
J Pharm Pharmacol; 2005 Mar; 57(3):273-85. PubMed ID: 15807982
[TBL] [Abstract][Full Text] [Related]
12. Biowaiver monographs for immediate release solid oral dosage forms: efavirenz.
Cristofoletti R; Nair A; Abrahamsson B; Groot DW; Kopp S; Langguth P; Polli JE; Shah VP; Dressman JB
J Pharm Sci; 2013 Feb; 102(2):318-29. PubMed ID: 23175470
[TBL] [Abstract][Full Text] [Related]
13. Case studies for practical food effect assessments across BCS/BDDCS class compounds using in silico, in vitro, and preclinical in vivo data.
Heimbach T; Xia B; Lin TH; He H
AAPS J; 2013 Jan; 15(1):143-58. PubMed ID: 23139017
[TBL] [Abstract][Full Text] [Related]
14. Regional intestinal drug permeation: biopharmaceutics and drug development.
Lennernäs H
Eur J Pharm Sci; 2014 Jun; 57():333-41. PubMed ID: 23988845
[TBL] [Abstract][Full Text] [Related]
15. The role of BCS (biopharmaceutics classification system) and BDDCS (biopharmaceutics drug disposition classification system) in drug development.
Benet LZ
J Pharm Sci; 2013 Jan; 102(1):34-42. PubMed ID: 23147500
[TBL] [Abstract][Full Text] [Related]
16. Application of data mining approach to identify drug subclasses based on solubility and permeability.
Gatarić B; Parojčić J
Biopharm Drug Dispos; 2019 Feb; 40(2):51-61. PubMed ID: 30635908
[TBL] [Abstract][Full Text] [Related]
17. [Research on attributes of biopharmaceutics classification system for Chinese materia medica of baicalein in Gegen Qinlian Decoction environment].
Liu Y; Yang L; Zhang X; Cheng YR; Gong YT; Dong L
Zhongguo Zhong Yao Za Zhi; 2019 Sep; 44(17):3653-3661. PubMed ID: 31602937
[TBL] [Abstract][Full Text] [Related]
18. The complexity of intestinal permeability: Assigning the correct BCS classification through careful data interpretation.
Zur M; Hanson AS; Dahan A
Eur J Pharm Sci; 2014 Sep; 61():11-7. PubMed ID: 24262076
[TBL] [Abstract][Full Text] [Related]
19. Interplay of biopharmaceutics, biopharmaceutics drug disposition and salivary excretion classification systems.
Idkaidek NM
Saudi Pharm J; 2014 Jan; 22(1):79-81. PubMed ID: 24493977
[TBL] [Abstract][Full Text] [Related]
20. Provisional classification and in silico study of biopharmaceutical system based on caco-2 cell permeability and dose number.
Pham-The H; Garrigues T; Bermejo M; González-Álvarez I; Monteagudo MC; Cabrera-Pérez MÁ
Mol Pharm; 2013 Jun; 10(6):2445-61. PubMed ID: 23675957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
